TXN and cancer: This oxidative mechanism is supposed to implicate the formation of highly reactive bis-Michael acceptor quinone methide-based intermediates capable of alkylating sulfur- and selenium donor cellular nucleophiles such as glutathione, thioredoxine- and ribonucleotid reductases vital to maintaining proliferation and redox balance of the cancer cells.